Skip to content

Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, sold RAPP on Aug 11, 2026

Data as of Oct 16

▼ SELL$937K19,500 shares at $48.04Abraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.
Watch RAPP
Traded
Aug 11, 2026
Disclosed
Aug 12, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, sold RAPP on Aug 11, 2026TRADEDDISCLOSED
RAPPSimilar stocks (S&P 500 (SPY)), rebased to RAPP's price on the disclosure day
RAPP since disclosure
−42.2%
after the sale
Similar stocks (SPY) since disclosure
−1.2%
S&P 500 (SPY)

Change in closing price from Aug 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$172Kdisclosed Aug 12 · filed 1 day after the trade
  2. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$282Kdisclosed Aug 12 · filed 1 day after the trade
  3. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$651Kdisclosed Aug 12 · filed 2 days after the trade
  4. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$391Kdisclosed Aug 12 · filed 2 days after the trade

See every trade on RAPP →